Review
doi: 10.1111/j.1365-2044.1997.084-az0080.x.
Cholinesterase. Its significance in anaesthetic practice
Affiliations
- PMID: 9124666
- DOI: 10.1111/j.1365-2044.1997.084-az0080.x
Item in Clipboard
Review
Cholinesterase. Its significance in anaesthetic practice
Anaesthesia.
1997 Mar.
Free article
Abstract
Plasma cholinesterase is an enzyme which has importance to the anaesthetist primarily for its role in the metabolism of suxamethonium, although other anaesthetic related drugs that this enzyme metabolises are also increasingly important. In this article we review current thoughts on the function, profile and chemistry of plasma cholinesterase. Causes of variations in the activity of the enzyme are described and the basis of genetic variations is explained.
Comment in
-
Remifentanil and cholinesterase.Anaesthesia. 1997 Jul;52(7):714. Anaesthesia. 1997. PMID: 9244049 No abstract available.
Similar articles
-
[Cholinesterases].Ann Fr Anesth Reanim. 1998;17(9):1122-35. doi: 10.1016/S0750-7658(00)80006-4. Ann Fr Anesth Reanim. 1998. PMID: 9835982 Review. French.
-
Clinical importance of plasma cholinesterase for the anaesthetist.Ann Acad Med Singap. 1994 Nov;23(6 Suppl):120-4. Ann Acad Med Singap. 1994. PMID: 7710221 Review.
-
Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.Anesthesiology. 1998 Sep;89(3):707-14. doi: 10.1097/00000542-199809000-00022. Anesthesiology. 1998. PMID: 9743409
-
Mivacurium-induced prolonged neuromuscular block.Br J Anaesth. 1995 Feb;74(2):234-6. doi: 10.1093/bja/74.2.234. Br J Anaesth. 1995. PMID: 7696076
-
Plasma cholinesterase variants and the anaesthetist.Anaesthesia. 1980 Feb;35(2):174-97. doi: 10.1111/j.1365-2044.1980.tb03800.x. Anaesthesia. 1980. PMID: 6992635 Review.
Cited by
-
Identifying key risk factors for acute compartment syndrome in tibial diaphysis fracture patients.Sci Rep. 2024 Apr 17;14(1):8913. doi: 10.1038/s41598-024-59669-1. Sci Rep. 2024. PMID: 38632464 Free PMC article.
-
Muscle relaxant use during intraoperative neurophysiologic monitoring.J Clin Monit Comput. 2013 Feb;27(1):35-46. doi: 10.1007/s10877-012-9399-0. Epub 2012 Sep 27. J Clin Monit Comput. 2013. PMID: 23015366 Review.
-
BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.J Immunol Res. 2022 Jul 21;2022:6051092. doi: 10.1155/2022/6051092. eCollection 2022. J Immunol Res. 2022. PMID: 35915658 Free PMC article.
-
A novel mutation in the BCHE gene and phenotype identified in a child with low butyrylcholinesterase activity: a case report.BMC Med Genet. 2018 Apr 10;19(1):58. doi: 10.1186/s12881-018-0561-5. BMC Med Genet. 2018. PMID: 29631548 Free PMC article.
-
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.Cancers (Basel). 2020 May 4;12(5):1154. doi: 10.3390/cancers12051154. Cancers (Basel). 2020. PMID: 32375339 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
